PortfoliosLab logo

Actinium Pharmaceuticals, Inc. (ATNM)

Equity · Currency in USD · Last updated Sep 27, 2022

Company Info

ISINUS00507W2061
CUSIP00507W206
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$7.91
Year Range$4.57 - $9.67
EMA (50)$6.65
EMA (200)$6.21
Average Volume$140.83K
Market Capitalization$199.21M

ATNMShare Price Chart


Chart placeholderClick Calculate to get results

ATNMPerformance

The chart shows the growth of $10,000 invested in Actinium Pharmaceuticals, Inc. in Jun 2012 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $22,121 for a total return of roughly 121.21%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%AprilMayJuneJulyAugustSeptember
43.13%
-20.58%
ATNM (Actinium Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ATNMReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M9.45%-9.92%
6M43.42%-19.55%
YTD21.46%-23.31%
1Y-24.51%-17.97%
5Y-16.04%7.93%
10Y10.02%9.20%

ATNMMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-9.98%-0.18%-5.37%17.03%-7.69%-12.86%2.49%42.60%3.84%
20211.03%2.28%-5.46%0.52%6.53%-3.06%-15.80%-8.71%45.72%-11.40%-8.66%-16.18%
202015.25%-5.02%-18.59%-4.90%15.28%65.26%63.95%-51.93%16.61%2.79%10.44%-29.09%
201943.41%5.41%-17.95%-36.46%6.56%-24.31%-5.37%-1.20%-0.00%8.48%8.22%-19.37%
20186.10%-38.93%-15.09%-1.97%7.54%66.28%2.22%-2.17%15.86%-18.68%-3.73%-33.33%
201721.14%33.02%7.09%0.00%-5.30%-14.69%-45.00%-9.09%-5.72%8.66%10.34%-3.76%
2016-34.37%-5.19%-1.00%-5.53%2.66%-8.29%0.56%1.12%-25.00%-29.63%6.31%-13.36%
2015-8.49%-42.12%-20.83%2.02%56.35%-32.74%-14.72%-7.08%-15.71%28.81%-5.70%50.23%
2014-3.23%-5.09%130.13%-11.73%10.65%-40.63%-12.60%-1.43%7.72%5.52%-18.81%2.61%
20130.00%0.00%293.33%-15.25%-38.00%1.61%20.63%-5.26%76.39%-23.62%46.19%-16.93%
2012-9.09%0.00%0.00%0.00%0.00%0.00%1,400.00%

ATNMSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Actinium Pharmaceuticals, Inc. Sharpe ratio is -0.40. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.40
-0.83
ATNM (Actinium Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ATNMDividend History


Actinium Pharmaceuticals, Inc. doesn't pay dividends

ATNMDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-98.15%
-23.80%
ATNM (Actinium Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ATNMWorst Drawdowns

The table below shows the maximum drawdowns of the Actinium Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Actinium Pharmaceuticals, Inc. is 98.84%, recorded on Mar 14, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.84%Apr 24, 20141987Mar 14, 2022
-58.67%Mar 25, 201332May 31, 201394Dec 9, 2013126
-32.13%Dec 11, 20139Dec 23, 201352Mar 12, 201461
-11.51%Mar 26, 20141Mar 26, 20143Mar 31, 20144
-10.7%Apr 4, 20142Apr 7, 201411Apr 23, 201413
-9.09%Jun 1, 20121Jun 1, 20121Dec 17, 20122
-4.17%Mar 17, 20142Mar 18, 20145Mar 25, 20147
-0.4%Apr 1, 20141Apr 1, 20141Apr 2, 20142

ATNMVolatility Chart

Current Actinium Pharmaceuticals, Inc. volatility is 44.16%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%AprilMayJuneJulyAugustSeptember
44.16%
13.19%
ATNM (Actinium Pharmaceuticals, Inc.)
Benchmark (^GSPC)